Dave Coulier Reveals Second Cancer Diagnosis, Undergoing Treatment

Dave Coulier, Full House star, revealed his second cancer diagnosis: HPV-related oropharyngeal tongue cancer. He is undergoing radiation treatment, emphasizing early detection.

L 40%
C 40%
R 20%

Overview

A summary of the key points of this story verified across multiple sources.

1.

Actor Dave Coulier, known from Full House, recently revealed his diagnosis with HPV-related oropharyngeal tongue cancer, specifically P16-positive squamous cell carcinoma.

2.

This marks Coulier's second cancer battle, coming seven months after he was declared cancer-free from stage three non-Hodgkin Lymphoma.

3.

Coulier is currently undergoing 35 rounds of radiation treatment, which are scheduled to conclude by December, for his current tongue cancer.

4.

Despite the diagnosis, P16 squamous carcinoma boasts a high curability rate exceeding 90%, offering a positive outlook for his recovery.

5.

Coulier advocates for early detection and regular check-ups, crediting his wife Melissa and family for support, and launched AwearMarket for wellness products.

Written using shared reports from
5 sources
.
Report issue

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Center-leaning sources are neutral in their coverage of Dave Coulier's cancer diagnosis. They present factual information directly from Coulier's statements and medical details without editorializing. The reporting focuses on conveying the news clearly, detailing his health journey, prognosis, and public health message, maintaining an objective and informative tone throughout.

Sources (5)

Compare how different news outlets are covering this story.

FAQ

Dig deeper on this story with frequently asked questions.

Dave Coulier was diagnosed with HPV-related oropharyngeal tongue cancer, specifically P16-positive squamous cell carcinoma.

His previous cancer diagnosis was stage three non-Hodgkin lymphoma, from which he was declared cancer-free seven months prior to his current diagnosis.

He is undergoing 35 rounds of radiation treatment, which are expected to conclude by December.

P16-positive squamous cell carcinoma associated with HPV has a high curability rate exceeding 90%, indicating a generally positive outlook for recovery.

Dave Coulier emphasizes the importance of early detection and regular medical check-ups to improve outcomes.

History

See how this story has evolved over time.

This story does not have any previous versions.